Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteoglycans in liver cancer.
Baghy K, Tátrai P, Regős E, Kovalszky I. Baghy K, et al. Among authors: regos e. World J Gastroenterol. 2016 Jan 7;22(1):379-93. doi: 10.3748/wjg.v22.i1.379. World J Gastroenterol. 2016. PMID: 26755884 Free PMC article. Review.
Syndecan-1 in Liver Diseases.
Regős E, Karászi K, Reszegi A, Kiss A, Schaff Z, Baghy K, Kovalszky I. Regős E, et al. Pathol Oncol Res. 2020 Apr;26(2):813-819. doi: 10.1007/s12253-019-00617-0. Epub 2019 Mar 2. Pathol Oncol Res. 2020. PMID: 30826971 Free PMC article.
Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice.
Reszegi A, Karászi K, Tóth G, Rada K, Váncza L, Turiák L, Schaff Z, Kiss A, Szilák L, Szabó G, Petővári G, Sebestyén A, Dezső K, Regős E, Tátrai P, Baghy K, Kovalszky I. Reszegi A, et al. Among authors: regos e. Cancers (Basel). 2021 Mar 27;13(7):1548. doi: 10.3390/cancers13071548. Cancers (Basel). 2021. PMID: 33801718 Free PMC article.
Syndecan-1 in liver pathophysiology.
Reszegi A, Tátrai P, Regős E, Kovalszky I, Baghy K. Reszegi A, et al. Among authors: regos e. Am J Physiol Cell Physiol. 2022 Aug 1;323(2):C289-C294. doi: 10.1152/ajpcell.00039.2022. Epub 2022 Jun 15. Am J Physiol Cell Physiol. 2022. PMID: 35704700 Free article. Review.
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study.
Gieszer B, Megyesfalvi Z, Dulai V, Papay J, Kovalszky I, Timar J, Fillinger J, Harko T, Pipek O, Teglasi V, Regos E, Papp G, Szallasi Z, Laszlo V, Renyi-Vamos F, Galffy G, Bodor C, Dome B, Moldvay J. Gieszer B, et al. Among authors: regos e. Transl Lung Cancer Res. 2021 Feb;10(2):662-674. doi: 10.21037/tlcr-20-814. Transl Lung Cancer Res. 2021. PMID: 33718012 Free PMC article.
13 results